An observational study in Ventral Hernias, sponsored by Cook Group Incorporated. Completed at 5 sites in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2017-06-15.
Sponsored by Cook Group Incorporated · Observational
The objective this study is to collect post-market data on the performance of the Zenapro™ Hybrid Hernia Repair Device when used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.
This study's enrollment of 63 is below the median of 120 across 327 observational studies indexed under Hernia.
Browse Hernia studies →Cook Group Incorporated is the lead sponsor of 73 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients from University of Tennessee, Duke University and Cleveland Clinic
Exclusion Criteria:
Device to be used to reinforce or bridge the abdominal wall for the repair of ventral hernias.
Device: Zenapro™ Hybrid Hernia Repair Device
Device will be placed during open or laparoscopic hernia repair.
Rate of hernia recurrence
Time frame: 12 months
This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cook Group Incorporated